High-dose chemotherapy for ERBB2-negative breast cancer.
Owen
Olwen Glynn
OG
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000532:radiotherapy; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008207:Lymphatic Metastasis; D011237:Predictive Value of Tests; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases; D016019:Survival Analysis
D018719:Erb-b2 Receptor Tyrosine Kinases